Indian Pharmaceutical Contract Manufacturing Market Research and Forecast 2018-2023
Pharmaceuticals companies have increasingly outsourced non-core activities with an aim to cut cost and focus on their capital management and management of research and marketing & sales. Many pharmaceuticals companies partnered with Indian pharmaceuticals contract manufacturer to manufacture various drugs and active pharmaceutical ingredients (API). For instance, GlaxoSmithKline Pharmaceuticals has started work on its largest greenfield tablet manufacturing facility in Vemgal in Kolar district, Karnataka, with an estimated investment of Rs 1,000 crore ($ 149.11 million). India stands 3rd in the pharmaceutical market in terms of volume and 13th in terms of value. According to Indian Brand Equity Foundation (IBEF), Indian Pharmaceutical sector is estimated to account for nearly 3.1 to 3.6% of the global pharmaceutical industry in terms of value and 10% in terms of volume. It is expected to reach $55 billion by 2020 and $100 billion by 2025. India is the major provider of generic drugs globally. India’s generics accounting for 20% of global exports (in volume terms).
Major factors contributing to the growth of the Indian pharmaceutical contract manufacturing market include increasing investments in the Indian pharmaceutical sector and government initiatives to promote the pharmaceutical sector and increasing trend of outsourcing of healthcare services. Indian Government has plans to incentivize bulk drug manufacturers, including both state-run and private companies, to encourage ‘Make in India’ programme and reduce dependence on imports of API, nearly 85% of which come from China. In addition, increasing pressure to minimize healthcare cost and availability of skilled workforce for low cost are another significant factor contributing in the market growth. However, stringent government regulations hinder the market growth. Moreover, rising demand for low cost services and increasing drug discovery is expected to create enormous opportunities for the Indian pharmaceuticals contract manufacturing market in near future.
The pharmaceutical contract manufacturing market can be segmented on the basis of category, type, product, and services. On the basis of category, the market is divided as human-based drugs and animals-based drugs. Based on type, the market is segmented into sterile manufacturing and non-sterile manufacturing. Based on the product, the market is bifurcated into OTC drugs, API, finished dosage forms include solid dose, liquid dose and injectable dose, and others such as nutritional products and packaging. Based on the services, the market is sub-divided as manufacturing services, non-clinical services and research and development. Among services, manufacturing segment is expected to be the highest revenue generating segment owing to growing medical device manufacturing. The growth of medical device manufacturing in emerging economies is expected to boost the manufacturing services segment.
Some of the key players operating in the Indian pharmaceutical contract manufacturing market are Aurobindo Pharma Limited, Jubilant Life Sciences Ltd. Dr Reddy’s Laboratories Ltd, Finecure Pharmaceuticals Limited, Gracure Pharmaceuticals Ltd., Jubilant Life Sciences Ltd. and Korten Pharmaceuticals Pvt. Ltd. These players adopt various strategies to sustain in the competitive market, such as merger & acquisitions, expansions, joint ventures and product development and partnership and collaboration. For instance, the major pharmaceutical companies such as GlaxoSmithKline are planning to open its new manufacturing facility in India, which is also further expected to boost the demand for contract manufacturing services in India. In 2016, Rubicon Research Pvt Ltd, a contract research and manufacturing services firm, is in advanced talks with Everstone Capital and a few high-net-worth Individuals (HNI) to raise up to Rs 240 crore ($35.79 million), which will be used to increase the company’s manufacturing capabilities.
RESEARCH METHODOLOGY
The market study of Indian pharmaceutical contract manufacturing market is incorporated by extensive primary and secondary research conducted by research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report country level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings the authenticity in our reports.
Secondary sources include:
Financial reports of companies involved in the market
Authentic Public Databases such as
Whitepapers, research-papers, and news blogs
Company websites and their product catalogue
Supplier Websites such as Alibaba, amazon for pricing analysis
The report is intended for drug manufacturers, healthcare provider, government organizations for overall market analysis, and competitive analysis. The report provides in-depth analysis on pricing, market size, intended quality of the product preferred by consumers, initial norms and vehicle segment. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models delivering insights into the market for better business decisions.
MARKET SEGMENTATION:
Indian Pharmaceutical Contract Manufacturing market is segmented on the basis of regional outlook and following segments:
Indian Pharmaceutical Contract Manufacturing Market Research and Analysis, By Category
Indian Pharmaceutical Contract Manufacturing Market Research and Analysis, By Type
Indian Pharmaceutical Contract Manufacturing Market Research and Analysis, By Product
Indian Pharmaceutical Contract Manufacturing Market Research and Analysis, By Services
THE REPORT COVERS:
Comprehensive research methodology of Indian Pharmaceutical Contract Manufacturing market.
This report also includes detailed and extensive market overview with key analyst insights.
Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
Analysis of regional regulations and other government policies impacting the Indian Pharmaceutical Contract Manufacturing market.
Insights about market determinants which are stimulating the Indian Pharmaceutical Contract Manufacturing market.
Detailed and extensive market segments with regional distribution of forecasted revenues.
Extensive profiles and recent developments of market players.
Major factors contributing to the growth of the Indian pharmaceutical contract manufacturing market include increasing investments in the Indian pharmaceutical sector and government initiatives to promote the pharmaceutical sector and increasing trend of outsourcing of healthcare services. Indian Government has plans to incentivize bulk drug manufacturers, including both state-run and private companies, to encourage ‘Make in India’ programme and reduce dependence on imports of API, nearly 85% of which come from China. In addition, increasing pressure to minimize healthcare cost and availability of skilled workforce for low cost are another significant factor contributing in the market growth. However, stringent government regulations hinder the market growth. Moreover, rising demand for low cost services and increasing drug discovery is expected to create enormous opportunities for the Indian pharmaceuticals contract manufacturing market in near future.
The pharmaceutical contract manufacturing market can be segmented on the basis of category, type, product, and services. On the basis of category, the market is divided as human-based drugs and animals-based drugs. Based on type, the market is segmented into sterile manufacturing and non-sterile manufacturing. Based on the product, the market is bifurcated into OTC drugs, API, finished dosage forms include solid dose, liquid dose and injectable dose, and others such as nutritional products and packaging. Based on the services, the market is sub-divided as manufacturing services, non-clinical services and research and development. Among services, manufacturing segment is expected to be the highest revenue generating segment owing to growing medical device manufacturing. The growth of medical device manufacturing in emerging economies is expected to boost the manufacturing services segment.
Some of the key players operating in the Indian pharmaceutical contract manufacturing market are Aurobindo Pharma Limited, Jubilant Life Sciences Ltd. Dr Reddy’s Laboratories Ltd, Finecure Pharmaceuticals Limited, Gracure Pharmaceuticals Ltd., Jubilant Life Sciences Ltd. and Korten Pharmaceuticals Pvt. Ltd. These players adopt various strategies to sustain in the competitive market, such as merger & acquisitions, expansions, joint ventures and product development and partnership and collaboration. For instance, the major pharmaceutical companies such as GlaxoSmithKline are planning to open its new manufacturing facility in India, which is also further expected to boost the demand for contract manufacturing services in India. In 2016, Rubicon Research Pvt Ltd, a contract research and manufacturing services firm, is in advanced talks with Everstone Capital and a few high-net-worth Individuals (HNI) to raise up to Rs 240 crore ($35.79 million), which will be used to increase the company’s manufacturing capabilities.
RESEARCH METHODOLOGY
The market study of Indian pharmaceutical contract manufacturing market is incorporated by extensive primary and secondary research conducted by research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report country level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings the authenticity in our reports.
Secondary sources include:
Financial reports of companies involved in the market
Authentic Public Databases such as
Whitepapers, research-papers, and news blogs
Company websites and their product catalogue
Supplier Websites such as Alibaba, amazon for pricing analysis
The report is intended for drug manufacturers, healthcare provider, government organizations for overall market analysis, and competitive analysis. The report provides in-depth analysis on pricing, market size, intended quality of the product preferred by consumers, initial norms and vehicle segment. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models delivering insights into the market for better business decisions.
MARKET SEGMENTATION:
Indian Pharmaceutical Contract Manufacturing market is segmented on the basis of regional outlook and following segments:
Indian Pharmaceutical Contract Manufacturing Market Research and Analysis, By Category
Indian Pharmaceutical Contract Manufacturing Market Research and Analysis, By Type
Indian Pharmaceutical Contract Manufacturing Market Research and Analysis, By Product
Indian Pharmaceutical Contract Manufacturing Market Research and Analysis, By Services
THE REPORT COVERS:
Comprehensive research methodology of Indian Pharmaceutical Contract Manufacturing market.
This report also includes detailed and extensive market overview with key analyst insights.
Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
Analysis of regional regulations and other government policies impacting the Indian Pharmaceutical Contract Manufacturing market.
Insights about market determinants which are stimulating the Indian Pharmaceutical Contract Manufacturing market.
Detailed and extensive market segments with regional distribution of forecasted revenues.
Extensive profiles and recent developments of market players.
CHAPTER 1. REPORT SUMMARY
1.1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN
1.2.1. BY SEGMENTS
1.2.2. BY STAKEHOLDERS
CHAPTER 2. MARKET OVERVIEW AND INSIGHTS
2.1. MARKET DEFINITION
2.2. GLOBAL PHARMACEUTICALS CONTRACT MANUFACTURING MARKET ANALYSIS
2.3. SUPPLY CHAIN ANALYSIS
2.4. ANALYST INSIGHT & CURRENT MARKET TRENDS
2.4.1. KEY FINDINGS
2.4.2. RECOMMENDATION
2.4.3. CONCLUSION
2.5. INDIAN RULES & REGULATIONS
CHAPTER 3. MARKET DETERMINANT
3.1. MOTIVATORS
3.1.1. INCREASING INVESTMENTS IN THE INDIAN PHARMACEUTICAL SECTOR
3.1.2. GOVERNMENT INITIATIVES TO PROMOTE THE PHARMACEUTICAL SECTOR
3.1.3. RISING TRENDS OF OUTSOURCING OF HEALTHCARE SERVICES
3.1.4. SPEEDY INTRODUCTION OF GENERIC DRUGS INTO THE MARKET
3.1.5. INCREASING PRESSURE TO MINIMIZE HEALTHCARE COST
3.1.6. AVAILABILITY OF SKILLED WORKFORCE FOR LOW COST
3.1.7. INCREASING DEMAND FOR DRUGS AND MEDICAL DEVICES COUPLED WITH RISING GERIATRIC POPULATION
3.2. RESTRAINTS
3.2.1. INCREASING RISK REGARDING OUTSOURCING
3.2.2. STRINGENT GOVERNMENT REGULATIONS
3.3. OPPORTUNITIES
3.3.1. INCREASING DRUG DISCOVERY AND COMPLEX CLINICAL TRIAL PROTOCOLS FUELS THE PHARMACEUTICAL OUTSOURCING
3.3.2. RISING DEMAND FOR LOW COST SERVICES
CHAPTER 4. MARKET SEGMENTATION
4.1. INDIAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY CATEGORY
4.1.1. HUMAN BASED DRUGS
4.1.2. ANIMALS BASED DRUGS
4.2. INDIAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY TYPE
4.2.1. STERILE MANUFACTURING
4.2.2. NON-STERILE MANUFACTURING
4.3. INDIAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY PRODUCT
4.3.1. OVER-THE-COUNTER (OTC) DRUGS
4.3.2. ACTIVE PHARMACEUTICAL INGREDIENTS (API)
4.3.3. FINISHED DOSAGE FORMULATION (SOLID DOSE, LIQUID DOSE AND INJECTABLE DOSE)
4.3.4. OTHERS (NUTRITIONAL PRODUCTS AND PACKAGING)
4.4. INDIAN PHARMACEUTICAL CONTRACT MANUFACTURING BY SERVICES
4.4.1. MANUFACTURING SERVICES
4.4.2. NON-CLINICAL SERVICES SUCH AS SUPPLY CHAIN MANAGEMENT
4.4.3. RESEARCH AND DEVELOPMENT
CHAPTER 5. COMPETITIVE LANDSCAPE
5.1. KEY COMPANY ANALYSIS
5.2. KEY STRATEGY ANALYSIS
CHAPTER 6. COMPANY PROFILES
6.1. AGRATA BIOTECH LTD.
6.2. ANKUR DRUGS AND PHARMA LTD.
6.3. AUROBINDO PHARMA
6.4. BDR PHARMACEUTICALS INTERNATIONALS PVT. LTD.
6.5. BLESSINGS HEALTH CARE PVT. LTD.
6.6. CEEGOLABS PVT LTD.
6.7. CIRON GROUP
6.8. CONTRACT PHARMACEUTICALS LTD.
6.9. COSWAY BIOSCIENCES
6.10. CUBIC LIFESCIENCES PVT LTD.
6.11. DAFFOHILS LABORATORIES PVT LTD.
6.12. DISHMAN GROUP
6.13. DIVIS LABORATORIES LTD.
6.14. DR REDDY’S LABORATORIES LTD.
6.15. DUPEN LABORATORIES
6.16. FINECURE PHARMACEUTICALS LTD.
6.17. GRACURE PHARMACEUTICALS LTD.
6.18. GREEN CROSS REMEDIES
6.19. HIRAL LABS LTD.
6.20. JUBILANT LIFE SCIENCES LTD.
6.21. KORTEN PHARMACEUTICALS PVT. LTD.
6.22. KOSHER PHARMACEUTICAL PVT. LTD.
6.23. KREMOINT PHARMA PVT. LTD.
6.24. LOGOS PHARMA
6.25. MAKJAI LABORATORIES PVT LTD.
6.26. MAXCHEM PHARMACEUTICALS PVT LTD.
6.27. MAXNOVA HEALTHCARE
6.28. MEDIPAAMS INDIA PVT. LTD.
6.29. MEDISYS BIOTECH PRIVATE LTD.
6.30. NIKOL FORMULATION PVT. LTD.
6.31. NUTRAGEN PHARMA PVT LTD.
6.32. NVRON LIFE SCIENCE LTD.
6.33. ORLIFE HEALTHCARE
6.34. PHARMA CONTRACT MANUFACTURING
6.35. PHARMASYNTH FORMULATIONS LTD.
6.36. PIRAMAL PHARMA SOLUTIONS
6.37. RADICO REMEDIES
6.38. RENOWN PHARMACEUTICALS PVT LTD.
6.39. SAIN MEDICAMENTS PVT. LTD
6.40. SAKAR HEALTHCARE PVT. LTD.
6.41. SAVA HEALTHCARE LTD.
6.42. SIGMA SOFTGEL & FORMULATION
6.43. SMITH&KENNER PHARMACEUTICALS PVT LTD.
6.44. SWISS BIOTECH
6.45. SYNCOM HEALTHCARE LTD.
6.46. SYNOKEM PHARMA
6.47. TREATWELL BIOTECH.
6.48. TUTTSAN PHARMA PVT. LTD.
6.49. VIBCARE PHARMA PVT. LTD.
6.50. VITAL THERAPEUTICS & FORMULATIONS PVT. LTD.
6.51. WELLONA PHARM
6.52. YASH PHARMA LABORATORIES PVT. LTD.
1.1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN
1.2.1. BY SEGMENTS
1.2.2. BY STAKEHOLDERS
CHAPTER 2. MARKET OVERVIEW AND INSIGHTS
2.1. MARKET DEFINITION
2.2. GLOBAL PHARMACEUTICALS CONTRACT MANUFACTURING MARKET ANALYSIS
2.3. SUPPLY CHAIN ANALYSIS
2.4. ANALYST INSIGHT & CURRENT MARKET TRENDS
2.4.1. KEY FINDINGS
2.4.2. RECOMMENDATION
2.4.3. CONCLUSION
2.5. INDIAN RULES & REGULATIONS
CHAPTER 3. MARKET DETERMINANT
3.1. MOTIVATORS
3.1.1. INCREASING INVESTMENTS IN THE INDIAN PHARMACEUTICAL SECTOR
3.1.2. GOVERNMENT INITIATIVES TO PROMOTE THE PHARMACEUTICAL SECTOR
3.1.3. RISING TRENDS OF OUTSOURCING OF HEALTHCARE SERVICES
3.1.4. SPEEDY INTRODUCTION OF GENERIC DRUGS INTO THE MARKET
3.1.5. INCREASING PRESSURE TO MINIMIZE HEALTHCARE COST
3.1.6. AVAILABILITY OF SKILLED WORKFORCE FOR LOW COST
3.1.7. INCREASING DEMAND FOR DRUGS AND MEDICAL DEVICES COUPLED WITH RISING GERIATRIC POPULATION
3.2. RESTRAINTS
3.2.1. INCREASING RISK REGARDING OUTSOURCING
3.2.2. STRINGENT GOVERNMENT REGULATIONS
3.3. OPPORTUNITIES
3.3.1. INCREASING DRUG DISCOVERY AND COMPLEX CLINICAL TRIAL PROTOCOLS FUELS THE PHARMACEUTICAL OUTSOURCING
3.3.2. RISING DEMAND FOR LOW COST SERVICES
CHAPTER 4. MARKET SEGMENTATION
4.1. INDIAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY CATEGORY
4.1.1. HUMAN BASED DRUGS
4.1.2. ANIMALS BASED DRUGS
4.2. INDIAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY TYPE
4.2.1. STERILE MANUFACTURING
4.2.2. NON-STERILE MANUFACTURING
4.3. INDIAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY PRODUCT
4.3.1. OVER-THE-COUNTER (OTC) DRUGS
4.3.2. ACTIVE PHARMACEUTICAL INGREDIENTS (API)
4.3.3. FINISHED DOSAGE FORMULATION (SOLID DOSE, LIQUID DOSE AND INJECTABLE DOSE)
4.3.4. OTHERS (NUTRITIONAL PRODUCTS AND PACKAGING)
4.4. INDIAN PHARMACEUTICAL CONTRACT MANUFACTURING BY SERVICES
4.4.1. MANUFACTURING SERVICES
4.4.2. NON-CLINICAL SERVICES SUCH AS SUPPLY CHAIN MANAGEMENT
4.4.3. RESEARCH AND DEVELOPMENT
CHAPTER 5. COMPETITIVE LANDSCAPE
5.1. KEY COMPANY ANALYSIS
5.2. KEY STRATEGY ANALYSIS
CHAPTER 6. COMPANY PROFILES
6.1. AGRATA BIOTECH LTD.
6.2. ANKUR DRUGS AND PHARMA LTD.
6.3. AUROBINDO PHARMA
6.4. BDR PHARMACEUTICALS INTERNATIONALS PVT. LTD.
6.5. BLESSINGS HEALTH CARE PVT. LTD.
6.6. CEEGOLABS PVT LTD.
6.7. CIRON GROUP
6.8. CONTRACT PHARMACEUTICALS LTD.
6.9. COSWAY BIOSCIENCES
6.10. CUBIC LIFESCIENCES PVT LTD.
6.11. DAFFOHILS LABORATORIES PVT LTD.
6.12. DISHMAN GROUP
6.13. DIVIS LABORATORIES LTD.
6.14. DR REDDY’S LABORATORIES LTD.
6.15. DUPEN LABORATORIES
6.16. FINECURE PHARMACEUTICALS LTD.
6.17. GRACURE PHARMACEUTICALS LTD.
6.18. GREEN CROSS REMEDIES
6.19. HIRAL LABS LTD.
6.20. JUBILANT LIFE SCIENCES LTD.
6.21. KORTEN PHARMACEUTICALS PVT. LTD.
6.22. KOSHER PHARMACEUTICAL PVT. LTD.
6.23. KREMOINT PHARMA PVT. LTD.
6.24. LOGOS PHARMA
6.25. MAKJAI LABORATORIES PVT LTD.
6.26. MAXCHEM PHARMACEUTICALS PVT LTD.
6.27. MAXNOVA HEALTHCARE
6.28. MEDIPAAMS INDIA PVT. LTD.
6.29. MEDISYS BIOTECH PRIVATE LTD.
6.30. NIKOL FORMULATION PVT. LTD.
6.31. NUTRAGEN PHARMA PVT LTD.
6.32. NVRON LIFE SCIENCE LTD.
6.33. ORLIFE HEALTHCARE
6.34. PHARMA CONTRACT MANUFACTURING
6.35. PHARMASYNTH FORMULATIONS LTD.
6.36. PIRAMAL PHARMA SOLUTIONS
6.37. RADICO REMEDIES
6.38. RENOWN PHARMACEUTICALS PVT LTD.
6.39. SAIN MEDICAMENTS PVT. LTD
6.40. SAKAR HEALTHCARE PVT. LTD.
6.41. SAVA HEALTHCARE LTD.
6.42. SIGMA SOFTGEL & FORMULATION
6.43. SMITH&KENNER PHARMACEUTICALS PVT LTD.
6.44. SWISS BIOTECH
6.45. SYNCOM HEALTHCARE LTD.
6.46. SYNOKEM PHARMA
6.47. TREATWELL BIOTECH.
6.48. TUTTSAN PHARMA PVT. LTD.
6.49. VIBCARE PHARMA PVT. LTD.
6.50. VITAL THERAPEUTICS & FORMULATIONS PVT. LTD.
6.51. WELLONA PHARM
6.52. YASH PHARMA LABORATORIES PVT. LTD.
LIST OF TABLES
TABLE 1 INDIAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET RESEARCH AND ANALYSIS BY CATEGORY, 2017-2023 ($ MILLION)
TABLE 2 INDIAN HUMAN BASED DRUGS MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 3 INDIAN ANIMALS BASED DRUGS MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 4 INDIAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET RESEARCH AND ANALYSIS BY TYPE, 2017-2023 ($ MILLION)
TABLE 5 INDIAN STERILE MANUFACTURING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 6 INDIAN NON-STERILE MANUFACTURING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 7 INDIAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2017-2023 ($ MILLION)
TABLE 8 INDIAN OTC DRUGS MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 9 INDIAN API MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 10 INDIAN FINISHED DOSAGE FORMULATION MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 11 INDIAN OTHERS MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 12 INDIAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET RESEARCH AND ANALYSIS BY SERVICES, 2017-2023 ($ MILLION)
TABLE 13 INDIAN MANUFACTURING SERVICES MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 14 INDIAN NON-CLINICAL SERVICES MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 15 INDIAN RESEARCH AND DEVELOPMENT MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 1 INDIAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET RESEARCH AND ANALYSIS BY CATEGORY, 2017-2023 ($ MILLION)
TABLE 2 INDIAN HUMAN BASED DRUGS MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 3 INDIAN ANIMALS BASED DRUGS MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 4 INDIAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET RESEARCH AND ANALYSIS BY TYPE, 2017-2023 ($ MILLION)
TABLE 5 INDIAN STERILE MANUFACTURING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 6 INDIAN NON-STERILE MANUFACTURING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 7 INDIAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2017-2023 ($ MILLION)
TABLE 8 INDIAN OTC DRUGS MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 9 INDIAN API MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 10 INDIAN FINISHED DOSAGE FORMULATION MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 11 INDIAN OTHERS MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 12 INDIAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET RESEARCH AND ANALYSIS BY SERVICES, 2017-2023 ($ MILLION)
TABLE 13 INDIAN MANUFACTURING SERVICES MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 14 INDIAN NON-CLINICAL SERVICES MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 15 INDIAN RESEARCH AND DEVELOPMENT MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
LIST OF FIGURES
FIGURE 1 INDIAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SHARE BY CATEGORY, 2017 VS 2023 (%)
FIGURE 2 INDIAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SHARE BY TYPE, 2017 VS 2023 (%)
FIGURE 3 INDIAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SHARE BY PRODUCT, 2017 VS 2023 (%)
FIGURE 4 INDIAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SHARE BY SERVICES, 2017 VS 2023 (%)
COMPANIES MENTIONED
1. AGRATA BIOTECH LTD.
2. ANKUR DRUGS AND PHARMA LTD.
3. AUROBINDO PHARMA
4. BDR PHARMACEUTICALS INTERNATIONALS PVT. LTD.
5. BLESSINGS HEALTH CARE PVT. LTD.
6. CEEGOLABS PVT LTD.
7. CIRON GROUP
8. CONTRACT PHARMACEUTICALS LTD.
9. COSWAY BIOSCIENCES
10. CUBIC LIFESCIENCES PVT LTD.
11. DAFFOHILS LABORATORIES PVT LTD.
12. DISHMAN GROUP
13. DIVIS LABORATORIES LTD.
14. DR REDDY’S LABORATORIES LTD.
15. DUPEN LABORATORIES
16. FINECURE PHARMACEUTICALS LTD.
17. GRACURE PHARMACEUTICALS LTD.
18. GREEN CROSS REMEDIES
19. HIRAL LABS LTD.
20. JUBILANT LIFE SCIENCES LTD.
21. KORTEN PHARMACEUTICALS PVT. LTD.
22. KOSHER PHARMACEUTICAL PVT. LTD.
23. KREMOINT PHARMA PVT. LTD.
24. LOGOS PHARMA
25. MAKJAI LABORATORIES PVT LTD.
26. MAXCHEM PHARMACEUTICALS PVT LTD.
27. MAXNOVA HEALTHCARE
28. MEDIPAAMS INDIA PVT. LTD.
29. MEDISYS BIOTECH PRIVATE LTD.
30. NIKOL FORMULATION PVT. LTD.
31. NUTRAGEN PHARMA PVT LTD.
32. NVRON LIFE SCIENCE LTD.
33. ORLIFE HEALTHCARE
34. PHARMA CONTRACT MANUFACTURING
35. PHARMASYNTH FORMULATIONS LTD.
36. PIRAMAL PHARMA SOLUTIONS
37. RADICO REMEDIES
38. RENOWN PHARMACEUTICALS PVT LTD.
39. SAIN MEDICAMENTS PVT. LTD
40. SAKAR HEALTHCARE PVT. LTD.
41. SAVA HEALTHCARE LTD.
42. SIGMA SOFTGEL & FORMULATION
43. SMITH&KENNER PHARMACEUTICALS PVT LTD.
44. SWISS BIOTECH
45. SYNCOM HEALTHCARE LTD.
46. SYNOKEM PHARMA
47. TREATWELL BIOTECH.
48. TUTTSAN PHARMA PVT. LTD.
49. VIBCARE PHARMA PVT. LTD.
50. VITAL THERAPEUTICS & FORMULATIONS PVT. LTD.
51. WELLONA PHARM
52. YASH PHARMA LABORATORIES PVT. LTD.
FIGURE 1 INDIAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SHARE BY CATEGORY, 2017 VS 2023 (%)
FIGURE 2 INDIAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SHARE BY TYPE, 2017 VS 2023 (%)
FIGURE 3 INDIAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SHARE BY PRODUCT, 2017 VS 2023 (%)
FIGURE 4 INDIAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SHARE BY SERVICES, 2017 VS 2023 (%)
COMPANIES MENTIONED
1. AGRATA BIOTECH LTD.
2. ANKUR DRUGS AND PHARMA LTD.
3. AUROBINDO PHARMA
4. BDR PHARMACEUTICALS INTERNATIONALS PVT. LTD.
5. BLESSINGS HEALTH CARE PVT. LTD.
6. CEEGOLABS PVT LTD.
7. CIRON GROUP
8. CONTRACT PHARMACEUTICALS LTD.
9. COSWAY BIOSCIENCES
10. CUBIC LIFESCIENCES PVT LTD.
11. DAFFOHILS LABORATORIES PVT LTD.
12. DISHMAN GROUP
13. DIVIS LABORATORIES LTD.
14. DR REDDY’S LABORATORIES LTD.
15. DUPEN LABORATORIES
16. FINECURE PHARMACEUTICALS LTD.
17. GRACURE PHARMACEUTICALS LTD.
18. GREEN CROSS REMEDIES
19. HIRAL LABS LTD.
20. JUBILANT LIFE SCIENCES LTD.
21. KORTEN PHARMACEUTICALS PVT. LTD.
22. KOSHER PHARMACEUTICAL PVT. LTD.
23. KREMOINT PHARMA PVT. LTD.
24. LOGOS PHARMA
25. MAKJAI LABORATORIES PVT LTD.
26. MAXCHEM PHARMACEUTICALS PVT LTD.
27. MAXNOVA HEALTHCARE
28. MEDIPAAMS INDIA PVT. LTD.
29. MEDISYS BIOTECH PRIVATE LTD.
30. NIKOL FORMULATION PVT. LTD.
31. NUTRAGEN PHARMA PVT LTD.
32. NVRON LIFE SCIENCE LTD.
33. ORLIFE HEALTHCARE
34. PHARMA CONTRACT MANUFACTURING
35. PHARMASYNTH FORMULATIONS LTD.
36. PIRAMAL PHARMA SOLUTIONS
37. RADICO REMEDIES
38. RENOWN PHARMACEUTICALS PVT LTD.
39. SAIN MEDICAMENTS PVT. LTD
40. SAKAR HEALTHCARE PVT. LTD.
41. SAVA HEALTHCARE LTD.
42. SIGMA SOFTGEL & FORMULATION
43. SMITH&KENNER PHARMACEUTICALS PVT LTD.
44. SWISS BIOTECH
45. SYNCOM HEALTHCARE LTD.
46. SYNOKEM PHARMA
47. TREATWELL BIOTECH.
48. TUTTSAN PHARMA PVT. LTD.
49. VIBCARE PHARMA PVT. LTD.
50. VITAL THERAPEUTICS & FORMULATIONS PVT. LTD.
51. WELLONA PHARM
52. YASH PHARMA LABORATORIES PVT. LTD.
